176 related articles for article (PubMed ID: 34116324)
1. Synthesis and structure-activity relationship of new chalcone linked 5-phenyl-3-isoxazolecarboxylic acid methyl esters potentially active against drug resistant Mycobacterium tuberculosis.
Sahoo SK; Rani B; Gaikwad NB; Ahmad MN; Kaul G; Shukla M; Nanduri S; Dasgupta A; Chopra S; Yaddanapudi VM
Eur J Med Chem; 2021 Oct; 222():113580. PubMed ID: 34116324
[TBL] [Abstract][Full Text] [Related]
2. Derivatives of 3-isoxazolecarboxylic acid esters: a potent and selective compound class against replicating and nonreplicating Mycobacterium tuberculosis.
Lilienkampf A; Pieroni M; Franzblau SG; Bishai WR; Kozikowski AP
Curr Top Med Chem; 2012; 12(7):729-34. PubMed ID: 22283815
[TBL] [Abstract][Full Text] [Related]
3. Antimycobacterial activity: synthesis of novel 3-(substituted phenyl)-6,7-dimethoxy-3a,4-dihydro-3H-indeno[1,2-c]isoxazole analogues.
Ali MA; Ismail R; Choon TS; Pandian S; Hassan Ansari MZ
J Enzyme Inhib Med Chem; 2011 Aug; 26(4):598-602. PubMed ID: 21714764
[TBL] [Abstract][Full Text] [Related]
4. Exploration of Isoxazole-Carboxylic Acid Methyl Ester Based 2-Substituted Quinoline Derivatives as Promising Antitubercular Agents.
Kumar Sahoo S; Naiyaz Ahmad M; Kaul G; Nanduri S; Dasgupta A; Chopra S; Madhavi Yaddanapudi V
Chem Biodivers; 2022 Jul; 19(7):e202200324. PubMed ID: 35653161
[TBL] [Abstract][Full Text] [Related]
5. Isoxazole carboxylic acid methyl ester-based urea and thiourea derivatives as promising antitubercular agents.
Sahoo SK; Ommi O; Maddipatla S; Singh P; Ahmad MN; Kaul G; Nanduri S; Dasgupta A; Chopra S; Yaddanapudi VM
Mol Divers; 2023 Oct; 27(5):2037-2052. PubMed ID: 36282413
[TBL] [Abstract][Full Text] [Related]
6. Rational design of 5-phenyl-3-isoxazolecarboxylic acid ethyl esters as growth inhibitors of Mycobacterium tuberculosis. a potent and selective series for further drug development.
Lilienkampf A; Pieroni M; Wan B; Wang Y; Franzblau SG; Kozikowski AP
J Med Chem; 2010 Jan; 53(2):678-88. PubMed ID: 20000577
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and evaluation of new quinazolin-4(3H)-one derivatives as potent antibacterial agents against multidrug resistant Staphylococcus aureus and Mycobacterium tuberculosis.
Gatadi S; Gour J; Shukla M; Kaul G; Dasgupta A; Madhavi YV; Chopra S; Nanduri S
Eur J Med Chem; 2019 Aug; 175():287-308. PubMed ID: 31096152
[TBL] [Abstract][Full Text] [Related]
8. Combating highly resistant emerging pathogen Mycobacterium abscessus and Mycobacterium tuberculosis with novel salicylanilide esters and carbamates.
Baranyai Z; Krátký M; Vinšová J; Szabó N; Senoner Z; Horváti K; Stolaříková J; Dávid S; Bősze S
Eur J Med Chem; 2015 Aug; 101():692-704. PubMed ID: 26210507
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis and antimycobacterial evaluation of 1-(4-(2-substitutedthiazol-4-yl)phenethyl)-4-(3-(4-substitutedpiperazin-1-yl)alkyl)piperazine hybrid analogues.
Nagesh HN; Suresh A; Sairam SD; Sriram D; Yogeeswari P; Chandra Sekhar KV
Eur J Med Chem; 2014 Sep; 84():605-13. PubMed ID: 25062011
[TBL] [Abstract][Full Text] [Related]
10. QSAR-driven design, synthesis and discovery of potent chalcone derivatives with antitubercular activity.
Gomes MN; Braga RC; Grzelak EM; Neves BJ; Muratov E; Ma R; Klein LL; Cho S; Oliveira GR; Franzblau SG; Andrade CH
Eur J Med Chem; 2017 Sep; 137():126-138. PubMed ID: 28582669
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and in vitro evaluation of novel substituted isatin-propylene-1H-1,2,3-triazole-4-methylene-moxifloxacin hybrids for their anti-mycobacterial activities.
Yan X; Lv Z; Wen J; Zhao S; Xu Z
Eur J Med Chem; 2018 Jan; 143():899-904. PubMed ID: 29227930
[TBL] [Abstract][Full Text] [Related]
12. Novel benzimidazole-acrylonitrile hybrids and their derivatives: Design, synthesis and antimycobacterial activity.
Sirim MM; Krishna VS; Sriram D; Unsal Tan O
Eur J Med Chem; 2020 Feb; 188():112010. PubMed ID: 31893548
[TBL] [Abstract][Full Text] [Related]
13. Azide-alkyne cycloaddition towards 1H-1,2,3-triazole-tethered gatifloxacin and isatin conjugates: Design, synthesis and in vitro anti-mycobacterial evaluation.
Xu Z; Song XF; Hu YQ; Qiang M; Lv ZS
Eur J Med Chem; 2017 Sep; 138():66-71. PubMed ID: 28646656
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis and anti-mycobacterial activity evaluation of benzofuran-isatin hybrids.
Gao F; Yang H; Lu T; Chen Z; Ma L; Xu Z; Schaffer P; Lu G
Eur J Med Chem; 2018 Nov; 159():277-281. PubMed ID: 30296686
[TBL] [Abstract][Full Text] [Related]
15. Design and synthesis of novel antimicrobials with activity against Gram-positive bacteria and mycobacterial species, including M. tuberculosis.
Tiruveedhula VV; Witzigmann CM; Verma R; Kabir MS; Rott M; Schwan WR; Medina-Bielski S; Lane M; Close W; Polanowski RL; Sherman D; Monte A; Deschamps JR; Cook JM
Bioorg Med Chem; 2013 Dec; 21(24):7830-40. PubMed ID: 24200931
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and antimycobacterial activities of ring-substituted quinolinecarboxylic acid/ester analogues. Part 1.
Vaitilingam B; Nayyar A; Palde PB; Monga V; Jain R; Kaur S; Singh PP
Bioorg Med Chem; 2004 Aug; 12(15):4179-88. PubMed ID: 15246094
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis and antimycobacterial activity of various 3-(4-(substitutedsulfonyl)piperazin-1-yl)benzo[d]isoxazole derivatives.
Naidu KM; Suresh A; Subbalakshmi J; Sriram D; Yogeeswari P; Raghavaiah P; Chandra Sekhar KV
Eur J Med Chem; 2014 Nov; 87():71-8. PubMed ID: 25240097
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and biological evaluation of moxifloxacin-acetyl-1,2,3-1H-triazole-methylene-isatin hybrids as potential anti-tubercular agents against both drug-susceptible and drug-resistant Mycobacterium tuberculosis strains.
Gao F; Chen Z; Ma L; Fan Y; Chen L; Lu G
Eur J Med Chem; 2019 Oct; 180():648-655. PubMed ID: 31352245
[TBL] [Abstract][Full Text] [Related]
19. Re-engineering nalidixic acid's chemical scaffold: A step towards the development of novel anti-tubercular and anti-bacterial leads for resistant pathogens.
Peraman R; Varma RV; Reddy YP
Bioorg Med Chem Lett; 2015 Oct; 25(19):4314-9. PubMed ID: 26277407
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis and biological activity of N-(amino)piperazine-containing benzothiazinones against Mycobacterium tuberculosis.
Wang A; Xu S; Chai Y; Xia G; Wang B; Lv K; Ma C; Wang D; Wang A; Qin X; Liu M; Lu Y
Eur J Med Chem; 2021 Jun; 218():113398. PubMed ID: 33823392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
